Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.
dc.contributor.author | Beksac, Meral | |
dc.contributor.author | Haznedar, Rauf | |
dc.contributor.author | Firatli-Tuglular, Tulin | |
dc.contributor.author | Ozdogu, Hakan | |
dc.contributor.author | Aydogdu, Ismet | |
dc.contributor.author | Konuk, Nahide | |
dc.contributor.author | Sucak, Gulsan | |
dc.date.accessioned | 2020-03-26T17:37:48Z | |
dc.date.available | 2020-03-26T17:37:48Z | |
dc.date.issued | 2009 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description | 51st Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2009 -- New Orleans, LA | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.description.sponsorship | Amer Soc Hematol | en_US |
dc.identifier.endpage | 747 | en_US |
dc.identifier.issn | 0006-4971 | en_US |
dc.identifier.issue | 22 | en_US |
dc.identifier.startpage | 746 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/23252 | |
dc.identifier.volume | 114 | en_US |
dc.identifier.wos | WOS:000272725802248 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | AMER SOC HEMATOLOGY | en_US |
dc.relation.ispartof | BLOOD | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group. | en_US |
dc.type | Conference Object | en_US |